Ultimovacs ASA Reports Fourth Quarter 2024 Financial Results and Provides General Business Update
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company…
Oslo, January 31, 2025: Ultimovacs ASA ("Ultimovacs") (OSE ULTI), a clinical-stage biotechnology company…
Sign in to your account